AI helps Stanford scientists discover a "natural Ozempic" with a surprising advantage
AI helps Stanford scientists discover a "natural Ozempic" with a surprising advantage
AI helps Stanford scientists discover a "natural Ozempic" with a surprising advantage
Key points
اہم نکات
मुख्य बातें
- Stanford Medicine researchers have found a naturally occurring molecule that could become a new kind of weight-loss treatment, after an AI tool helped them discover it.
- The molecule, called BRP, cut food intake by up to 50 percent within an hour in mice and minipigs, and reduced body weight, while avoiding side effects common with Ozempic such as nausea and muscle loss.
- Unlike semaglutide, which acts on receptors across the body, BRP appears to work mainly in the hypothalamus, the brain's appetite-control centre.
- Stanford Medicine researchers have found a naturally occurring molecule that could become a new kind of weight-loss treatment, after an AI tool helped them discover it.
- The molecule, called BRP, cut food intake by up to 50 percent within an hour in mice and minipigs, and reduced body weight, while avoiding side effects common with Ozempic such as nausea and muscle loss.
- Unlike semaglutide, which acts on receptors across the body, BRP appears to work mainly in the hypothalamus, the brain's appetite-control centre.
- Stanford Medicine researchers have found a naturally occurring molecule that could become a new kind of weight-loss treatment, after an AI tool helped them discover it.
- The molecule, called BRP, cut food intake by up to 50 percent within an hour in mice and minipigs, and reduced body weight, while avoiding side effects common with Ozempic such as nausea and muscle loss.
- Unlike semaglutide, which acts on receptors across the body, BRP appears to work mainly in the hypothalamus, the brain's appetite-control centre.
Stanford Medicine researchers have found a naturally occurring molecule that could become a new kind of weight-loss treatment, after an AI tool helped them discover it. The molecule, called BRP, cut food intake by up to 50 percent within an hour in mice and minipigs, and reduced body weight, while avoiding side effects common with Ozempic such as nausea and muscle loss. Unlike semaglutide, which acts on receptors across the body, BRP appears to work mainly in the hypothalamus, the brain's appetite-control centre. The work is still at the animal stage, and human trials are the next step.
Stanford Medicine researchers have found a naturally occurring molecule that could become a new kind of weight-loss treatment, after an AI tool helped them discover it. The molecule, called BRP, cut food intake by up to 50 percent within an hour in mice and minipigs, and reduced body weight, while avoiding side effects common with Ozempic such as nausea and muscle loss. Unlike semaglutide, which acts on receptors across the body, BRP appears to work mainly in the hypothalamus, the brain's appetite-control centre. The work is still at the animal stage, and human trials are the next step.
Stanford Medicine researchers have found a naturally occurring molecule that could become a new kind of weight-loss treatment, after an AI tool helped them discover it. The molecule, called BRP, cut food intake by up to 50 percent within an hour in mice and minipigs, and reduced body weight, while avoiding side effects common with Ozempic such as nausea and muscle loss. Unlike semaglutide, which acts on receptors across the body, BRP appears to work mainly in the hypothalamus, the brain's appetite-control centre. The work is still at the animal stage, and human trials are the next step.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।